1Stiles MK, Dahbous OH, Fox KA, et al. Bleeding events with antithrombotic therapy in patients with unstable angina or non-ST-segment elevation myocardial infarction: insight from a large clinical practice registry (GRACE) [J]. Heart Lung Circ,2008,17(1 ):5-8.
2Topoi EJ, Easton D, Harrington RA, et al. Randomized, double-blindl placebo controlled, international trial of the oral Ⅱ b/Ⅲ/a antagonist lotrafiban in coronary and cerebrovaseular disease [J]. Circulation, 2003, 108 (4): 399-406.
3Sun JC,Whitlock R,Cheng J,et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies [J]. Eur Heart J,2008,29(8) :1057- 1071.
4Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis[J]. BMJ, 2000,321 (7270) : 1183-I 187.
5Aronow HD, Steinhubl SR, Brennan DM, et al. Bleeding risk associated with 1 years of dual antiplatelet theprapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial[J]. Am Heart J,2009,157(2): 369-374.
6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J]. N Engl J Med, 2001,345(7) : 494-502.
7Eagle KA, Gore JM, Anderson FA, et al. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (GRACE) [JJ. Am J Cardiol, 2005, 96(1) :917-921.
8Labinaz M, Ho C, Banerjee S, et al. Meta-analysis of clinical efficacy and bleeding risk with intravenous glyeoprotein Ⅱ b/Ⅲ a antagonists for percutaneous coronary intervention[J]. Can J Cardiol, 2007,23 (12) : 963-970.
9Kastrati A, Mehilli J, Neumann FJ, et al. Abeiximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial[J]. JAMA, 2006,295(13) : 1531-1538.
10Eikelboom JW, Anand SS, Malmberg K, et al. Unfractionated heparin and low molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis[J]. Lancet, 2000,355(9219) : 1936-1942.
